Correction to “New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance”

Detalles Bibliográficos
Autores principales: Kalathil, Akil A., Guin, Subham, Ashokan, Akash, Basu, Uttara, Surnar, Bapurao, Delma, Katiana S., Lima, Leonor M., Kryvenko, Oleksandr N., Dhar, Shanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450869/
https://www.ncbi.nlm.nih.gov/pubmed/37637725
http://dx.doi.org/10.1021/acscentsci.3c00920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450869/
https://www.ncbi.nlm.nih.gov/pubmed/37637725
http://dx.doi.org/10.1021/acscentsci.3c00920

Ejemplares similares